1. Home
  2. CLSD vs ELBM Comparison

CLSD vs ELBM Comparison

Compare CLSD & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • ELBM
  • Stock Information
  • Founded
  • CLSD 2011
  • ELBM 2011
  • Country
  • CLSD United States
  • ELBM Canada
  • Employees
  • CLSD N/A
  • ELBM N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • ELBM Industrial Machinery/Components
  • Sector
  • CLSD Health Care
  • ELBM Miscellaneous
  • Exchange
  • CLSD Nasdaq
  • ELBM Nasdaq
  • Market Cap
  • CLSD 20.4M
  • ELBM 19.2M
  • IPO Year
  • CLSD 2016
  • ELBM N/A
  • Fundamental
  • Price
  • CLSD $3.68
  • ELBM $1.47
  • Analyst Decision
  • CLSD Hold
  • ELBM Strong Buy
  • Analyst Count
  • CLSD 4
  • ELBM 2
  • Target Price
  • CLSD $65.00
  • ELBM $2.20
  • AVG Volume (30 Days)
  • CLSD 29.9K
  • ELBM 21.9M
  • Earning Date
  • CLSD 11-07-2025
  • ELBM 11-14-2025
  • Dividend Yield
  • CLSD N/A
  • ELBM N/A
  • EPS Growth
  • CLSD N/A
  • ELBM N/A
  • EPS
  • CLSD N/A
  • ELBM N/A
  • Revenue
  • CLSD $4,166,000.00
  • ELBM N/A
  • Revenue This Year
  • CLSD $98.20
  • ELBM N/A
  • Revenue Next Year
  • CLSD $213.77
  • ELBM N/A
  • P/E Ratio
  • CLSD N/A
  • ELBM N/A
  • Revenue Growth
  • CLSD N/A
  • ELBM N/A
  • 52 Week Low
  • CLSD $3.32
  • ELBM $0.77
  • 52 Week High
  • CLSD $17.40
  • ELBM $8.70
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 51.21
  • ELBM 47.45
  • Support Level
  • CLSD $3.68
  • ELBM $1.31
  • Resistance Level
  • CLSD $4.08
  • ELBM $1.91
  • Average True Range (ATR)
  • CLSD 0.26
  • ELBM 1.02
  • MACD
  • CLSD -0.13
  • ELBM -0.18
  • Stochastic Oscillator
  • CLSD 2.86
  • ELBM 2.16

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

Share on Social Networks: